{"id":56972,"date":"2024-02-27T17:16:42","date_gmt":"2024-02-27T17:16:42","guid":{"rendered":"https:\/\/medsname.com\/ezedoc\/"},"modified":"2026-05-01T10:49:13","modified_gmt":"2026-05-01T10:49:13","slug":"ezedoc","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/ezedoc\/","title":{"rendered":"Ezedoc"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns Rapid \u2014 Ce este Ezedoc?<\/h3>\n<p style=\"margin:0;\"><strong>Ezedoc<\/strong> con\u021bine <strong>ezetimibe<\/strong> (10 mg), un <strong>inhibitor al absorb\u021biei de colesterol<\/strong> care blocheaz\u0103 transportorul NPC1L1 \u00een intestinul sub\u021bire. Este <strong>terapia de completare preferat\u0103 atunci c\u00e2nd un statin singur nu ajunge la \u021bint\u0103 pentru LDL. Singur, ezetimibul reduce LDL-C cu aproximativ 17\u201322%. Ad\u0103ugat la un statin, produce o reducere suplimentar\u0103 de ~20\u201325% a LDL, totaliz\u00e2nd o sc\u0103dere de 55\u201360% \u2014 echivalent cu dublarea dozei de statin f\u0103r\u0103 efectele adverse musculare sau hepatice legate de doz\u0103. Studiul<\/strong>. IMPROVE-IT <strong>(18.144 pacien\u021bi post-ACS) a demonstrat c\u0103 ad\u0103ugarea ezetimibului la simvastatin reduce \u00een continuare evenimentele cardiovasculare. Doz\u0103: 10 mg o dat\u0103 pe zi, \u00een orice moment, cu sau f\u0103r\u0103 m\u00e2ncare. \u00cen general foarte bine tolerat \u2014 tulbur\u0103ri gastrointestinale u\u0219oare, mialgii ocazionale, eleva\u021bii rare ale transaminazelor. Evita\u021bi \u00een insuficien\u021b\u0103 hepatic\u0103 sever\u0103.<\/strong> Ce este Ezedoc?.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ezedoc este un medicament hipolipemiant oral care con\u021bine<\/h2>\n<p>(10 mg), fabricat de un produc\u0103tor certificat WHO-GMP. Furnizat \u00een cutii de 30, 60, 90 sau 180 de comprimate. Ezetimibul este primul \u0219i singurul medicament din clasa <strong>ezetimibe<\/strong> . Marc\u0103 original\u0103: <strong>inhibitor al absorb\u021biei de colesterol<\/strong> Zetia \/ Ezetrol <strong>(Merck, 2002).<\/strong> Ezetimibul este un pilon al managementului lipidic de linia a doua \u2014 prima alegere atunci c\u00e2nd ave\u021bi nevoie de o reducere mai mare a LDL dec\u00e2t ofer\u0103 o doz\u0103 tolerat\u0103 de statin sau c\u00e2nd un pacient nu tolereaz\u0103 doze mai mari de statine. Este, de asemenea, cel mai frecvent partener \u00een combina\u021bii cu doz\u0103 fix\u0103 (simvastatin\/ezetimib = Inegy\/Vytorin; rosuvastatin\/ezetimib = diverse).<\/p>\n<p>Pentru ce se folose\u0219te Ezedoc?.<\/p>\n<h2 class=\"wp-block-heading\">\u2014 ca terapie de completare la un statin atunci c\u00e2nd LDL nu atinge \u021binta la doza maxim\u0103 tolerat\u0103 de statin<\/h2>\n<ul>\n<li><strong>Hipercolesterolemie primar\u0103<\/strong> \u2014 as add-on to a statin when LDL is not at goal on the maximum tolerated statin dose<\/li>\n<li><strong>Intoleran\u021b\u0103 la statine<\/strong> \u2014 ca monoterapie sau cu o doz\u0103 foarte mic\u0103 de statin\u0103 atunci c\u00e2nd o doz\u0103 complet\u0103 provoac\u0103 probleme musculare sau hepatice<\/li>\n<li><strong>Hipercolesterolemie familial\u0103<\/strong> (heterozigot \u0219i homozigot) \u2014 \u00een combina\u021bie cu statina<\/li>\n<li><strong>Preven\u021bie secundar\u0103 dup\u0103 sindromul coronarian acut<\/strong> \u2014 ad\u0103ugare la statin\u0103 pentru a reduce \u00een continuare evenimentele cardiovasculare (studiu IMPROVE-IT)<\/li>\n<li><strong>Sitosterolemie<\/strong> \u2014 o afec\u021biune genetic\u0103 rar\u0103 \u00een care ezetimiba are efect modificator al bolii<\/li>\n<\/ul>\n<p>Ezetimiba este slab\u0103 ca monoterapie (~17% reducere LDL) \u00een compara\u021bie cu o statin\u0103 (~30\u201360%); este cea mai eficient\u0103 ca terapie adjunctiv\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Ezedoc?<\/h2>\n<p>Ezetimiba inhib\u0103 selectiv <strong>transportorul Niemann-Pick C1-Like 1 (NPC1L1)<\/strong> de pe enterocitele din intestinul sub\u021bire proximal. NPC1L1 este responsabil pentru absorb\u021bia colesterolului alimentar \u0219i biliar din lumenul intestinal \u00een enterocit.<\/p>\n<p>Cu NPC1L1 blocat:<\/p>\n<ul>\n<li><strong>Absorb\u021bia intestinal\u0103 a colesterolului scade cu ~54%<\/strong><\/li>\n<li><strong>Depozitele hepatice de colesterol scad<\/strong> deoarece mai pu\u021bin colesterol ajunge la ficat<\/li>\n<li><strong>receptorii LDL sunt regla\u021bi \u00een sus<\/strong> pe hepatocite \u2014 ficatul extrage mai mult LDL din s\u00e2nge<\/li>\n<li><strong>LDL-C plasmatic scade cu 17\u201322%<\/strong> ca monoterapie; p\u00e2n\u0103 la 25% suplimentar atunci c\u00e2nd este combinat cu un statin<\/li>\n<li>activitatea HMG-CoA reductazei (\u021binta statinelor) este neschimbat\u0103<\/li>\n<\/ul>\n<p>Deoarece ezetimiba \u0219i statinele ac\u021bioneaz\u0103 asupra <strong>c\u0103ilor complementare<\/strong> (absorb\u021bie vs sintez\u0103), efectele lor sunt aditive. Statinele reduc sinteza LDL; ezetimiba reduce absorb\u021bia\/inputul LDL. \u00cempreun\u0103 reduc LDL mai mult dec\u00e2t oricare ar putea singure, f\u0103r\u0103 a ad\u0103uga la profilul de efecte adverse al celuilalt.<\/p>\n<p>Date de rezultat: <strong>Studiul IMPROVE-IT<\/strong> (2015) a demonstrat c\u0103 ad\u0103ugarea ezetimibe la simvastatin la pacien\u021bii post-SCA a redus punctul final CV compozit cu 6,4% (NNT 50 pe 7 ani), confirm\u00e2nd c\u0103 sc\u0103derea LDL se traduce \u00eentr-o reducere real\u0103 a evenimentelor.<\/p>\n<h2 class=\"wp-block-heading\">Doza \u0219i administrare<\/h2>\n<p><strong>Doza standard:<\/strong> 10 mg o dat\u0103 pe zi \u00een orice moment al zilei, cu sau f\u0103r\u0103 m\u00e2ncare.<\/p>\n<ul>\n<li>Lua\u021bi la aceea\u0219i or\u0103 pentru respectarea tratamentului.<\/li>\n<li>Poate fi luat \u00een acela\u0219i timp cu un statin sau la intervale separate \u2014 nu exist\u0103 interac\u021biune de timp.<\/li>\n<li>Dac\u0103 a\u021bi uitat o doz\u0103 \u2014 lua\u021bi-o c\u00e2t mai cur\u00e2nd v\u0103 aminti\u021bi, cu excep\u021bia cazului \u00een care este aproape de urm\u0103toarea; nu dubla\u021bi doza.<\/li>\n<li>Nu este necesar\u0103 ajustarea dozei pentru insuficien\u021b\u0103 renal\u0103 sau insuficien\u021b\u0103 hepatic\u0103 u\u0219oar\u0103 p\u00e2n\u0103 la moderat\u0103.<\/li>\n<li>Monitoriza\u021bi panelul lipidic \u0219i ALT la baz\u0103 \u0219i la 6\u20138 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eenceperea tratamentului. Verifica\u021bi CK numai dac\u0103 apar simptome.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p>Ezetimibe este unul dintre cele mai bine tolerate medicamente hipolipemiante. Evenimentele adverse sunt aproape de ratele placebo \u00een studii.<\/p>\n<p><strong>Frecvente (&lt; 5%):<\/strong><\/p>\n<ul>\n<li>Diaree u\u0219oar\u0103, flatulen\u021b\u0103<\/li>\n<li>Infec\u021bie ale tractului respirator superior, sinuzit\u0103<\/li>\n<li>Oboseal\u0103<\/li>\n<li>Artralgie<\/li>\n<\/ul>\n<p><strong>Mai pu\u021bin frecvente:<\/strong><\/p>\n<ul>\n<li>Cre\u0219terea transaminazelor \u2014 de obicei mic\u0103; mai frecvent\u0103 atunci c\u00e2nd este combinat\u0103 cu un statin<\/li>\n<li>Durere muscular\u0103, mialgie, miopatie \u2014 rar\u0103; \u00een principal atunci c\u00e2nd este combinat\u0103 cu statin<\/li>\n<li>Hipersensibilitate, angioedem, erup\u021bie cutanat\u0103<\/li>\n<li>Pancreatit\u0103 \u2014 foarte rar\u0103<\/li>\n<li>Colelitiaz\u0103 \u2014 foarte rar\u0103<\/li>\n<li>Trombocitopenie \u2014 foarte rar\u0103<\/li>\n<li>Rabdomioliz\u0103 \u2014 extrem de rar\u0103, aproape \u00eentotdeauna \u00een combina\u021bie cu un statin<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Ciclosporin\u0103<\/strong> \u2014 cre\u0219te semnificativ nivelurile de ezetimib\u0103 (\u0219i invers). Monitora\u021bi nivelurile de ciclosporin\u0103; unele recomand\u0103ri sugereaz\u0103 evitarea.<\/li>\n<li><strong>Sequestran\u021bi de acizi biliari<\/strong> (colestiramin\u0103, colestipol) \u2014 reduc absorb\u021bia ezetimibei; administra\u021bi ezetimib\u0103 cu cel pu\u021bin 2 ore \u00eenainte sau 4 ore dup\u0103.<\/li>\n<li><strong>Warfarin<\/strong> \u2014 modific\u0103ri ocazionale ale INR raportate; monitoriza\u021bi la \u00eenceput.<\/li>\n<li><strong>Statine<\/strong> \u2014 nicio interac\u021biune PK advers\u0103; aceast\u0103 combina\u021bie reprezint\u0103 baza terapeutic\u0103.<\/li>\n<li><strong>Fibrate<\/strong> \u2014 combina\u021bia fenofibrat\/ezetimib\u0103 este sigur\u0103; gemfibrozilul cre\u0219te nivelurile de ezetimib\u0103 \u0219i este \u00een general evitat.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cine nu ar trebui s\u0103 ia Ezedoc?<\/h2>\n<ul>\n<li>Insuficien\u021b\u0103 hepatic\u0103 moderat\u0103 p\u00e2n\u0103 la sever\u0103 (c\u00e2nd este combinat\u0103 cu un statin)<\/li>\n<li>Boal\u0103 hepatic\u0103 activ\u0103 sau cre\u0219tere persistent\u0103 a transaminazelor &gt; 3\u00d7 ULN<\/li>\n<li>Sarcin\u0103 (c\u00e2nd este combinat cu un statin)<\/li>\n<li>Al\u0103ptare<\/li>\n<li>Copii &lt; 10 ani (date insuficiente)<\/li>\n<li>Hipersensibilitate cunoscut\u0103 la ezetimib\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Ezedoc sub 25\u00b0C \u00eentr-un loc uscat, \u00een blisterul original. Depozita\u021bi \u00eentr-un loc inaccesibil copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Pot lua Ezedoc \u00een locul unui statin?<\/h3>\n<p>De obicei nu. Ca monoterapie, ezetimiba reduce LDL cu doar ~17% \u2014 mult mai pu\u021bin dec\u00e2t un statin (30\u201360%). Este potrivit\u0103 ca monoterapie doar pentru pacien\u021bii care nu tolereaz\u0103 niciun statin \u00een nicio doz\u0103. Pentru majoritatea oamenilor, cea mai bun\u0103 strategie de reducere a lipidelor este statinul mai \u00eent\u00e2i, iar ezetimiba ad\u0103ugat\u0103 dac\u0103 LDL r\u0103m\u00e2ne peste \u021bint\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Cum se compar\u0103 Ezedoc cu dublarea dozei de statin?<\/h3>\n<p>Dublarea dozei de statin adaug\u0103 de obicei o reducere de ~6% a LDL (\u201cregula celor 6\u201d a statinelor). Ad\u0103ugarea ezetimibei adaug\u0103 o reducere de ~20\u201325% a LDL. <strong>Ad\u0103ugarea ezetimibei este de 3\u20134 ori mai eficient\u0103<\/strong> dec\u00e2t dublarea statinului, f\u0103r\u0103 cre\u0219terea simptomelor musculare legate de doz\u0103. Acesta este motivul pentru care ghidurile moderne recomand\u0103 combina\u021bia statin + ezetimib\u0103 \u00een loc de cre\u0219terea statinului la doza maxim\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Reduce Ezedoc infarctul miocardic \u0219i accidentul vascular cerebral?<\/h3>\n<p>Da \u2014 studiul IMPROVE-IT (18.144 pacien\u021bi post-SCA) a demonstrat c\u0103 ad\u0103ugarea ezetimibei la simvastatin\u0103 a redus punctul final compus de deces CV, IM, angin\u0103 instabil\u0103, revascularizare sau AVC cu 6,4% pe parcursul a 7 ani. Aceasta este dovada emblematic\u0103 c\u0103 reducerea LDL dincolo de statine singure \u00eenc\u0103 se traduce \u00een beneficii cardiovasculare reale.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2nd ar trebui s\u0103 iau Ezedoc?<\/h3>\n<p>Orice moment al zilei este potrivit. Spre deosebire de simvastatin\u0103 (preferabil seara), momentul administr\u0103rii ezetimibei nu depinde de doz\u0103 \u2014 alege\u021bi un moment pe care \u00eel ve\u021bi re\u021bine \u00een mod constant. Mul\u021bi pacien\u021bi o iau \u00een acela\u0219i timp cu statina lor.<\/p>\n<h3 class=\"wp-block-heading\">Cauzeaz\u0103 Ezedoc dureri musculare ca statinele?<\/h3>\n<p>Rar. Monoterapia cu ezetimib\u0103 prezint\u0103 efecte secundare musculare la nivel de placebo. Atunci c\u00e2nd este combinat\u0103 cu o statin\u0103, nu cre\u0219te semnificativ simptomele musculare legate de statin\u0103 \u00een compara\u021bie cu statina singur\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Ezedoc online?<\/h3>\n<p>Pute\u021bi comanda Ezedoc (10 mg) de la MedsBase \u00een cutii de 30, 60, 90 sau 180 de comprimate. Livr\u0103m \u00een \u00eentreaga lume cu ambalaj discret \u0219i stocuri autentice de la produc\u0103tori certifica\u021bi WHO-GMP.<\/p>\n<h2 class=\"wp-block-heading\">Medicamente \u00eenrudite pentru colesterol<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lipvas\/\">Lipvas \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/crestor\/\">Crestor \u2014 Rosuvastatin 5\/10\/20 mg (AstraZeneca)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/rosuline\/\">Rosuline \u2014 Rosuvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/atorvatin\/\">Atorvatin \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/pivasta\/\">Pivasta \u2014 Pitavastatin (cu interac\u021biuni reduse)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lipicard\/\">Lipicard \u2014 Fenofibrat (pentru trigliceride)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-cholesterol-treatments\/\"><strong>R\u0103sfoi\u021bi toate medicamentele pentru colesterol ridicat<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are doar scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui profesionist calificat din domeniul s\u0103n\u0103t\u0103\u021bii. Dureri musculare neexplicate, g\u0103lbirea pielii sau a ochilor sau dureri abdominale severe necesit\u0103 evaluare medical\u0103 imediat\u0103.<\/div>\n<h3 class=\"wp-block-heading\">De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Ezedoc este furnizat printr-un produc\u0103tor certificat WHO-GMP cu documenta\u021bie COA complet\u0103. Livr\u0103m \u00een \u00eentreaga lume \u00een ambalaje simple \u0219i discrete, iar fiecare comand\u0103 este acoperit\u0103 de <a href=\"\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>. Descrierea tranzac\u021biei la plata cu cardul afi\u0219eaz\u0103 procesatorul de pl\u0103\u021bi reglementat (un procesator de pl\u0103\u021bi cu card reglementat), niciodat\u0103 \u201cMedsBase\u201d sau nume de medicamente.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/bencid\/\">Bencid<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tiova-rotacaps\/\">Tiova Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/serobid-rotacaps\/\">Serobid Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/headset\/\">Casc\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/xafinact\/\">Xafinact<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Reduceaz\u0103 Nivelul Colesterolului<br \/>\n\u2705 Reduce riscul de boli cardiace<br \/>\n\u2705 Previne Ateroscleroza<br \/>\n\u2705 Prescris de Medici<br \/>\n\u2705 Op\u021biune de medicament oral<\/p>\n<p>Ezedoc con\u021bine Ezetimibe.<\/p>","protected":false},"featured_media":56973,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3953],"product_tag":[4210,4211],"class_list":{"0":"post-56972","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-high-cholesterol-treatments","9":"product_tag-ezedoc","10":"product_tag-ezetimibe","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/56972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=56972"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/56973"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=56972"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=56972"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=56972"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=56972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}